Dr Maycock's draft letter stated that there was always the problem of non-B hepatitis which he said American authorities thought accounted for 90% of transfusion associated hepatitis and which opened a "new vista of complications."
Linked evidence
Chronology Information
Date:
Chapter/issue
Pharmaceutical Companies
Key Person(s)
Sir William Maycock